Speaking to Vascular News at the 2026 Vascular Annual Meeting (VAM), peripheral arterial disease (PAD) expert Anahita Dua (Masschusetts General Hospital, Boston, USA) explains the rationale behind her institution’s “target protocol”—a precision medicine approach to thromboprophylaxis aimed at spurring wound healing and amputation prevention. Dua delivered this year’s Frank J Veith Distinguished Lecture on Advances in PAD and Limb Salvage on the topic.
Most read
Features
Profiles
